PA
Perceptive Advisors’s Axsome Therapeutics AXSM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.7M | Sell |
198,534
-156,573
| -44% | -$16.3M | 0.77% | 35 |
|
|
2025
Q1 | $41.4M | Sell |
355,107
-308,967
| -47% | -$36M | 1.46% | 20 |
|
|
2024
Q4 | $56.2M | Sell |
664,074
-118,770
| -15% | -$10M | 1.55% | 20 |
|
|
2024
Q3 | $70.4M | Buy |
782,844
+323,733
| +71% | +$29.1M | 1.49% | 19 |
|
|
2024
Q2 | $37M | Sell |
459,111
-646,230
| -58% | -$52M | 0.89% | 32 |
|
|
2024
Q1 | $88.2M | Buy |
1,105,341
+67,322
| +6% | +$5.37M | 1.54% | 21 |
|
|
2023
Q4 | $82.6M | Buy |
1,038,019
+556,370
| +116% | +$44.3M | 1.84% | 12 |
|
|
2023
Q3 | $33.7M | Buy |
481,649
+210,156
| +77% | +$14.7M | 1.12% | 28 |
|
|
2023
Q2 | $19.5M | Buy |
+271,493
| New | +$19.5M | 0.56% | 51 |
|
|
2022
Q1 | – | Sell |
-80,420
| Closed | -$3.04M | – | 137 |
|
|
2021
Q4 | $3.04M | Hold |
80,420
| – | – | 0.05% | 128 |
|
|
2021
Q3 | $2.65M | Sell |
80,420
-473,488
| -85% | -$15.6M | 0.04% | 127 |
|
|
2021
Q2 | $37.4M | Buy |
+553,908
| New | +$37.4M | 0.48% | 52 |
|
|
2020
Q3 | – | Sell |
-50,000
| Closed | -$4.11M | – | 129 |
|
|
2020
Q2 | $4.11M | Buy |
+50,000
| New | +$4.11M | 0.07% | 96 |
|
|
2019
Q4 | – | Sell |
-53,879
| Closed | -$1.09M | – | 112 |
|
|
2019
Q3 | $1.09M | Hold |
53,879
| – | – | 0.03% | 85 |
|
|
2019
Q2 | $1.39M | Hold |
53,879
| – | – | 0.03% | 88 |
|
|
2019
Q1 | $767K | Buy |
+53,879
| New | +$767K | 0.02% | 88 |
|